Dr. Timothy Wilens, M.D., is an associate professor of psychiatry at Harvard Medical School in Boston and a psychiatrist at Massachusetts General Hospital.

Walt Karniski, M.D., is a developmental pediatrician. He has evaluated and treated children with ADHD, autism, anxiety, learning disabilities, and other developmental difficulties. He currently resides in Tampa, Florida.

William Dodson, M.D., is a speaker, consultant, and writer on adult ADHD medicine. He is a Board-Certified adult Psychiatrist with a private consulting practice in Denver, CO.

Dr. Fazekas is both a licensed clinical psychologist & board certified psychiatric nurse practitioner. His practice is limited to the evaluation and medical treatment of adult ADHD.

Welcome! Dr. Sheenie Ambardar, MD is a Beverly Hills-based ADHD Psychiatrist, Psychotherapist, and Coach who sees adults throughout California via telehealth. Dr. Ambardar specializes in the diagnosis and treatment of adult men and women with ADHD.

Well Coast Medical provides psychiatric evaluations, medication & therapy for children, teens & adults in California & Oregon. We specialize in ADHD/ADD and offer videoconference and in-person appointments. Accepting most insurances and Medicare

Dr. Brandemihl is a board certified general Psychiatrist specializing in medication management and psychotherapy for adult patients and adolescents in their late teens. He is experienced in treating a variety of disorders including ADD/ADHD.

Houston MD, ADHD specialist providing ADHD testing including TOVA computerized test, & NEBA Brainwave analysis. Dr. Manny Ahmad has 22+ years treating pediatric ADHD and related conditions. Serving children & adults. Most insurances accepted.

Dr. Sharma completed residency and training at The University of Virginia. He's board certified in adult, child and adolescent psychiatry. Dr. Sharma’s interests include mood and anxiety disorders in adults, ADHD and disruptive behavior disorders.

Dr. Adrian Jacques Ambrose specializes in treatment-refractory mood disorders for both the adult, child, and adolescent populations in interventional and novel therapeutics, such as neuronavigated TMS, ketamine, and psychedelics.